CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Hospira's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 13, 2024Fail-Safe Drug Infusion Therapy System1
Jul 18, 2018Methods Of Treating Pediatric Patients Using Dexmedetomidine1
Apr 11, 2018Dexmedetomidine Premix Formulation1

Top competitors of Hospira

Top competitors of Hospira based on patent oppositions.